Adma Biologics | ADMA - 当期純利益





当期純利益 変化する 日付
Adma Biologics USD 49.38M 12.95M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Novavax USD 17.53M 219.91M 2025-12
Omeros USD -32.23M 23.81M 2024-09
Takeda JPY 103.64B 115.44B 2025-12